Beijing Enze Kangtai Biotechnology

Beijing Enze Kangtai Biotechnology, operating under the brand Echo-Bio, is a leading Chinese biotechnology company specializing in the development of exosome-based therapeutics and diagnostics. Founded in 2017, the company leverages its proprietary engineered exosome platform to create innovative drug delivery systems and therapeutic candidates for oncology, rare diseases, and inflammatory conditions. Enze Kangtai's core technology focuses on the efficient loading of various cargoes, including small molecules and nucleic acids, into exosomes for targeted delivery. The company has established a comprehensive ecosystem covering exosome research, clinical transformation, and large-scale GMP manufacturing. With significant backing from prominent venture capital firms, Enze Kangtai is advancing a pipeline of internal and partnered programs toward clinical validation.